comparemela.com
Home
Live Updates
Aurinia Pharmaceuticals Inc.: Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results : comparemela.com
Aurinia Pharmaceuticals Inc.: Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results
$34.4 million in net revenue for the first quarter of 2023; an increase of 59% over the first quarter of the prior year Increases 2023 revenue guidance range to $135 $155 million from net product
Related Keywords
Canada ,
United Kingdom ,
Rockville ,
Maryland ,
United States ,
Switzerland ,
Canadian ,
Peter Greenleaf ,
Toni Braxton ,
Aurinia Pharmaceuticals Inc ,
Company Quarterly Report On Form ,
Aurinia Pharmaceuticals ,
United Kingdom National Institute For Health ,
Exchange Commission Electronic Document Gathering ,
Company Annual Report On Form ,
Nasdaq ,
Chief Executive Officer ,
Grammy Award ,
Get Uncomfortable ,
National Institute ,
Care Excellence ,
Three Months Ended March ,
Quarterly Report ,
Annual Report ,
Canadian Securities Administrator System ,
Electronic Document Analysis ,
Exchange Commission ,
Electronic Document Gathering ,
Retrieval System ,
Aurinia ,
Pharmaceuticals ,
Reports ,
First ,
Quarter ,
023 ,
Financial ,
Perational ,
Results ,
comparemela.com © 2020. All Rights Reserved.